Published in N Engl J Med on March 06, 1997
ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol (2015) 3.04
Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials. PLoS Clin Trials (2007) 1.54
Misuse of correlation and regression in three medical journals. J R Soc Med (1999) 1.09
Sexual dimorphism in ischemic stroke: lessons from the laboratory. Womens Health (Lond Engl) (2011) 1.00
Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99
Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol (2005) 0.92
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J (2009) 0.89
Acute and chronic effects of oestrogen on endothelial tissue-type plasminogen activator release in postmenopausal women. J Physiol (2003) 0.86
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. Hypertension (2008) 0.81
Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women. Clin Auton Res (2005) 0.79
High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene. J Steroid Biochem Mol Biol (2004) 0.79
Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann Surg (1998) 0.78
Estrogen-eluting stents. J Cardiovasc Transl Res (2009) 0.76
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review. Int J Endocrinol (2014) 0.76
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial. Ecancermedicalscience (2008) 0.76
Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr (2013) 0.76
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart (1998) 0.75
Colorectal cancers and chlorinated water. World J Gastrointest Oncol (2016) 0.75
Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease? Curr Control Trials Cardiovasc Med (2001) 0.75
The influence of sex steroid hormones on the response to trauma and burn injury. Burns Trauma (2017) 0.75
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet (1994) 3.22
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med (2000) 2.97
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med (1994) 2.80
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A (2000) 2.41
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation (1995) 1.84
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest (1995) 1.69
Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation (1994) 1.66
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis (2000) 1.66
Oral L-arginine in patients with coronary artery disease on medical management. Circulation (2000) 1.65
Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension (1998) 1.61
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol (1997) 1.61
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med (1990) 1.55
Abnormalities in bilirubin and liver enzyme levels in adult patients with bacteremia. A prospective study. Arch Intern Med (1989) 1.53
In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun (1992) 1.52
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. Am J Cardiol (1991) 1.48
Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol (2001) 1.48
Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis (1992) 1.46
A 10-year analysis of "revenues," costs, staffing, and workload in an academic medical center clinical chemistry laboratory. Clin Chem (1993) 1.45
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation (1994) 1.45
Biochemical analysis of thyroid cyst fluid obtained by fine-needle aspiration. Arch Pathol Lab Med (1993) 1.44
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. Am J Cardiol (1988) 1.42
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol (1990) 1.40
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation (1992) 1.39
Acute vascular effects of estrogen in postmenopausal women. Circulation (1994) 1.39
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension (1997) 1.38
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation (1995) 1.38
Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension (1999) 1.34
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.32
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Hypertension (1998) 1.26
Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol (1999) 1.25
Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation (2001) 1.24
Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation (1999) 1.24
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol (1995) 1.22
Cardiovascular complications in renal failure. J Am Soc Nephrol (1991) 1.21
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation (1985) 1.21
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem (2001) 1.21
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2011) 1.21
Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation (1999) 1.19
Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res (2010) 1.18
Clinical evaluation of impedance cardiography. Clin Physiol (1986) 1.18
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension (1997) 1.18
Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation (1992) 1.17
Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial. Sex Transm Dis (1998) 1.17
Structure, biosynthesis, and function of salivary mucins. Mol Cell Biochem (1994) 1.17
Systemic amyloidosis presenting with angina pectoris. Ann Intern Med (1999) 1.16
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation (2000) 1.14
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation (1997) 1.14
Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women. Am J Cardiol (1995) 1.14
Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension (1998) 1.12
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension (2000) 1.12
Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis (1992) 1.12
Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ Res (2000) 1.10
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med (1987) 1.07
Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol (2001) 1.07
Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation (1996) 1.03
Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique. Circulation (2001) 1.03
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.02
Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem (1994) 1.01
Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy. Am J Cardiol (1993) 1.00
Changes in self-esteem in black and white girls between the ages of 9 and 14 years. The NHLBI Growth and Health Study. J Adolesc Health (1998) 1.00
Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment. Pharmacotherapy (1988) 0.99
Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation (2000) 0.98
Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol (1985) 0.98
Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol (1997) 0.98
Giant right coronary aneurysm: CT angiographic and echocardiographic findings. AJR Am J Roentgenol (2001) 0.98
Chest pain as a consequence of abnormal visceral nociception. Dig Dis Sci (1993) 0.98
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 0.97
C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules. J Immunol (1976) 0.97
Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation (2000) 0.97
Hemodynamic principles in the control of coronary blood flow. Am J Cardiol (1985) 0.97
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol (2001) 0.97
Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol (2000) 0.96
Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation (1992) 0.96
Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol (1997) 0.94
Treatment of suspected postcholecystectomy diarrhea with psyllium hydrophilic mucilloid. Clin Pharm (1990) 0.94
Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation (1999) 0.94